Radke, Joshua B. http://orcid.org/0000-0002-5215-1463
Melillo, Bruno http://orcid.org/0000-0002-9708-5287
Mittal, Payal
Sharma, Manmohan
Sharma, Amit
Fu, Yong
Uddin, Taher
Gonse, Arthur
Comer, Eamon
Schreiber, Stuart L.
Gupta, Anil K.
Chatterjee, Arnab K.
Sibley, L. David http://orcid.org/0000-0001-7110-0285
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI143857, AI143857)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Article History
Received: 3 June 2021
Accepted: 10 January 2022
First Online: 24 January 2022
Competing interests
: The Broad Institute Inc., the President and Fellows of Harvard College, and Washington University have applied for a patent (PCT/US2019/051686 listing J.B.R., E.C., B.M. and L.D.S. as inventors) for the use of bicyclic azetidines for antiparasitic therapies. All other authors declare no competing interests.